Genetic silencing of SF3B1 only displayed a tumor‐suppressive effect in a PDAC cell line harboring SF3B1 mutation but not wild‐type SF3B1, suggesting a change‐of‐function of SF3B1 mutation in PDAC. This evidence concerns the gene SF3B1 and neoplasm.